Special Report on Sida Piezoelectric KNN Lead-Free Medical Atomization Chip
Home / News / Company News / Special Report on Sida Piezoelectric KNN Lead-Free Medical Atomization Chip

Special Report on Sida Piezoelectric KNN Lead-Free Medical Atomization Chip

2026-09-14
Share:

Non-toxic Safety, Environmental Compliance, and Global Industry Trends Analysis

1. Product Development Overview

To meet global demand for high-end lead-free atomization components, our company has advanced the development of the KNN lead-free medical atomization chip. Utilizing a lead-free potassium sodium niobate material system, this product maintains equivalent core performance and atomization efficiency to traditional lead-containing chips while achieving comprehensive improvements in material safety, production processes, and environmental friendliness. Its higher operating frequency enables finer atomization, enhances drug absorption efficiency, and eliminates lead leaching risks, fundamentally addressing safety and environmental concerns associated with conventional products. The chip is suitable for various applications including household use, medical settings, wellness care, and premium eco-friendly home products.

2. Core Product Advantages:

Comprehensive non-toxic safety assurance. Traditional atomization chips contain lead, a toxic substance that may leach during use and pose health risks to sensitive populations.

This KNN lead-free chip is manufactured from environmentally friendly materials, preventing the leaching of heavy metals and completely eliminating pollution risks. After passing safety tests and being approved for medical use, the product addresses critical safety concerns and enhances safety standards, with a smooth certification process obtained from the U.S. FDA.

Meanwhile, we have addressed the challenge of small particle size coupled with low atomization efficiency: when MMAD is below 5 μm, the atomization rate can reach 0.6 mL/min or even 0.8-1.0 mL/min, meeting customers' demand for fine particles and high atomization output. This represents our groundbreaking core technology for lead-free atomization chips and a key achievement in responding to global environmental compliance requirements through innovation.

3. Compliance Assurance:

Strict adherence to global RoHS environmental standards. With tightening global environmental regulations, EU RoHS and China RoHS have become mandatory requirements, with lead being a key controlled substance. The 2026 RoHS draft will further restrict lead exemptions, making lead-free compliance a mandatory requirement.

The KNN lead-free chip strictly complies with RoHS standards, undergoes comprehensive quality control throughout the manufacturing process, meets all restricted substance limits, and is globally certified—effectively eliminating compliance and market risks associated with traditional lead-containing products.

Meanwhile, its production process eliminates lead-containing steps, features low energy consumption and low emissions, meets green production standards, and helps downstream enterprises comply with environmental audits while mitigating operational risks.

4. Industry Trends:

Lead-free development is an irreversible trend in the global atomization industry. In the global piezoelectric atomization component sector, lead-free substitution has become a core trend. Countries continue to introduce regulations tightening the use of lead-containing electronic components, particularly for medical and household devices, where lead-free compliance has become a fundamental requirement.

From the perspective of market demand, with the growing awareness of consumer health and environmental protection, end-users have raised higher requirements for the safety and eco-friendliness of medical and health products. Lead-free and non-toxic products have become the mainstream choice among consumers, while traditional lead-containing products have seen weakened market competitiveness.

From an industrial evolution perspective, global industry leaders have accelerated their efforts in developing and mass-producing lead-free atomization chips. Technological advancements have rapidly improved the performance and cost-effectiveness of lead-free products, enabling their gradual and comprehensive replacement of lead-containing alternatives. The domestic industry has also entered a phase of green transformation, with lead-free components becoming pivotal for building premium brands and expanding overseas markets.

In the long term, as global environmental protection and medical safety standards improve, lead-containing aerosol products will gradually phase out, with lead-free solutions applicable across all scenarios becoming the ultimate standard. Our company has focused on developing KNN lead-free chips to capitalize on industry trends and secure a leading market position.

5. Product Value and Industrial Significance

The development of this KNN lead-free medical nebulization chip represents not only a significant technological breakthrough for our company, but also a strategic move aligned with industry compliance upgrades, responsive to global green development initiatives, and crucial for safeguarding public health. In terms of product value, it combines four key advantages: high performance, enhanced safety, strict compliance, and premium pricing. While maintaining consistent nebulization treatment efficacy, it significantly elevates the safety standards and quality profile of end-user devices, enabling differentiated competition and high-end upgrading for downstream products, thereby strengthening brand reputation and creating greater price differentiation potential.

From an industrial value perspective, this product overcomes the technical and regulatory limitations of traditional lead-containing nebulization devices, driving the advancement of medical nebulization components toward non-toxicity, environmental friendliness, and high-end performance. It helps China's nebulization industry align with global top-tier environmental and safety standards while enhancing the international competitiveness of domestically produced core nebulization components. In terms of social value, it eliminates heavy metal toxicity and environmental pollution at the source, balancing human health protection with ecological conservation and embodying the principles of green and sustainable development.

Our company has focused on developing KNN lead-free atomization chips, enabling customers' atomizers to capitalize on industry trends and secure a leading market position, ultimately benefiting people worldwide. Controllable atomization rate and median particle size, customizable.

6. Future Development Plan:

Going forward, our company will continue to advance the research and development of lead-free atomization chip technology, optimize the formulation and manufacturing process of KNN materials, further enhance product atomization efficiency, operational stability, and service life, and achieve large-scale, low-cost mass production.

Meanwhile, we will continue to monitor updates to global RoHS regulations and advancements in medical safety standards, optimize our product compliance management system, and accelerate product certification processes. Going forward, leveraging lead-free atomization chips as our core technology, we are committed to expanding its applications in healthcare, home appliances, and smart health, while consistently delivering environmentally friendly, safe, and high-performance core components to drive high-quality, lead-free, and sustainable development in the atomization industry.

Going forward, we will continue to leverage this leading advantage, fully tap into technological potential, further optimize product performance to meet customized demands across various sectors such as healthcare and home use, strengthen our technological competitiveness, and contribute significantly to advancing the lead-free and sustainable development of the entire aerosol industry.

QQ20260914-001118

Test Details No. Frequency (KHz) Capacitance (nF) Impedance (ohm) No-load Current Spray Current (mA) Spray Power (W) Visual Nebulization Nebulization Volume ml/min MMAD μm
1 123 2.63 52 250 1.25 0.88 3.89
2 123 2.74 72 250 1.25 0.81 4.45
3 122 2.72 106 250 1.25 1.17 4.45
4 123 2.58 57 250 1.25 0.93 4.51
5 122 2.76 63 250 1.25 0.80 4.19
6 122 2.59 72 250 1.25 0.73 3.66
7 124 2.56 51 250 1.25 0.99 4.53
8 123 2.48 80 250 1.25 0.88 4.85
9 122 2.62 65 250 1.25 0.95 4.00
10 123 2.75 47 250 1.25
Average 122.7 2.643 66.5 250.0 1.25 0.90 4.28

Production Date Model No. Product Requirement Nebulization Rate (ml/min) MMAD (μm)
20260708 KNN16-140K MMAD<10μm, Nebulization Volume 2ml/min 1.45~2.1 7~8.08
20260708 KNN16-140K MMAD<5μm, Nebulization Volume 0.8~1.0ml/min 0.6~0.85 3.88~4.32
20260715 KNN13.8-170K MMAD<10μm, Nebulization Volume 2ml/min 0.93~1.49 8.31~10.62
2026.7.22 KNN13.8-170K MMAD<5μm, Nebulization Volume 0.8~1.0ml/min 0.89-1.18 4.25-5.15



Haining Saida Piezoelectric Ceramics Co., Ltd.
Mesh Nebulization Research Center